LU79655A1 - PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING A NITRO-IMIDAZOLE - Google Patents

PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING A NITRO-IMIDAZOLE

Info

Publication number
LU79655A1
LU79655A1 LU79655A LU79655A LU79655A1 LU 79655 A1 LU79655 A1 LU 79655A1 LU 79655 A LU79655 A LU 79655A LU 79655 A LU79655 A LU 79655A LU 79655 A1 LU79655 A1 LU 79655A1
Authority
LU
Luxembourg
Prior art keywords
imidazole
nitro
preparing
pharmaceutical composition
composition containing
Prior art date
Application number
LU79655A
Other languages
French (fr)
Inventor
M Fawzi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU79655A1 publication Critical patent/LU79655A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU79655A 1977-05-14 1978-05-12 PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING A NITRO-IMIDAZOLE LU79655A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2037977 1977-05-14

Publications (1)

Publication Number Publication Date
LU79655A1 true LU79655A1 (en) 1979-12-06

Family

ID=10144988

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79655A LU79655A1 (en) 1977-05-14 1978-05-12 PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING A NITRO-IMIDAZOLE

Country Status (16)

Country Link
JP (1) JPS542315A (en)
AU (1) AU504551B1 (en)
BE (1) BE867040A (en)
DE (1) DE2820992A1 (en)
DK (1) DK212678A (en)
ES (1) ES469749A1 (en)
FI (1) FI781507A (en)
FR (1) FR2390162A1 (en)
IL (1) IL54687A0 (en)
IT (1) IT1115599B (en)
LU (1) LU79655A1 (en)
NL (1) NL7805158A (en)
NO (1) NO781688L (en)
PT (1) PT68034B (en)
SE (1) SE7805471L (en)
ZA (1) ZA782736B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070778D1 (en) * 1979-08-11 1985-07-25 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
FR2624736B1 (en) * 1987-12-16 1991-03-22 Dietlin Francois NEW WATER-DISPERSIBLE PHARMACEUTICAL COMPOSITIONS BASED ON ORNIDAZOLE
CN104127379A (en) * 2014-08-14 2014-11-05 珠海亿邦制药股份有限公司 Ornidazole injection and preparation method thereof
CN110538144A (en) * 2019-06-13 2019-12-06 南京瓦尔生物医药有限公司 Ornidazole injection and S-ornidazole injection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032645A (en) * 1975-06-19 1977-06-28 G. D. Searle & Co. Injectable metronidazole composition

Also Published As

Publication number Publication date
PT68034B (en) 1979-10-24
DK212678A (en) 1978-11-15
ES469749A1 (en) 1978-12-16
ZA782736B (en) 1979-05-30
DE2820992A1 (en) 1978-12-07
FR2390162A1 (en) 1978-12-08
BE867040A (en) 1978-11-13
NL7805158A (en) 1978-11-16
NO781688L (en) 1978-11-15
PT68034A (en) 1978-06-01
AU504551B1 (en) 1979-10-18
JPS542315A (en) 1979-01-09
FI781507A (en) 1978-11-15
IT7823351A0 (en) 1978-05-12
IL54687A0 (en) 1978-07-31
IT1115599B (en) 1986-02-03
SE7805471L (en) 1978-11-15

Similar Documents

Publication Publication Date Title
PT67365A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
PT68448A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NOVEL ORGANIC COMPOUNDS
FR2411839B1 (en) CEPHALOSPORANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
BE866880A (en) PROCESS FOR PREPARING A POWDER CONTAINING NON-HYGROSCOPIC LACTULOSE
BE879472A (en) PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DIHYDRO-3-OXO-2-QUINOXALINES
PT66850A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
PT68306A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
PT66120A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
FR2306962A1 (en) PROCESS FOR PREPARING ALKYLENEGLYCOLS
PT67522B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION WITH NEW ORGANIC COMPOUNDS
LU79655A1 (en) PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING A NITRO-IMIDAZOLE
PT65264B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING ORGANIC COMPOUNDS
PT67562B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
LU78177A1 (en) PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING L OR LD PHENYLGLYCINS (RACEMICS)
PT68062B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
PT68216A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
PT68091A (en) PROCESS FOR THE PREPARATION OF A HERBICID COMPOSITION CONTAINING DIURETANE
PT67791A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING ORGANIC COMPOUNDS
PT68345A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
PT65970A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
PT70855A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
PT68218A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS
FR2275525A1 (en) PROCESS FOR PREPARING A POLYMERISABLE (CO) COMPOSITION
PT66166A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NOVEL ORGANIC COMPOUNDS
PT64839A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS